Bimekizumab Shows Consistent Long-Term Safety in PsA and axSpA

Summary: A new study shows that a medicine called bimekizumab is safe to use long-term for two types of painful joint conditions: psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA). Researchers looked at data from over 2,200 patients and found that the medicine did not cause any new or surprising health problems over time.

The most common side effects were cold-like symptoms, COVID-19, and mild oral thrush. Serious problems, like heart issues or cancer, were very rare and did not increase with the medicine. Overall, doctors believe the benefits of using this medicine outweigh the risks for people suffering from these joint diseases.

For more details, see rssapp-clinicaladvisor-com at clinicaladvisor.com/news/bimekizumab-shows-consistent-long-term-safety-psa-axspa/ (opens in new tab)